About: http://webisa.webdatacommons.org/229375616

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	But, he added, Our best guess is that more studies would have to be done before FDA or other regulatory agencies would consider approving solanezumab.
http://www.w3.org/ns/prov#wasQuotedFrom	ibj.com